AzTrials
AzTrials

FractureGlobal POISENCT05361980

Pediatric Orthopaedic Implant Safety & Efficacy

An observational study of Fracture and Lengthening; Leg, run by University of British Columbia at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity. Given the vital role fixation devices play in maintaining alignment, promoting healthy bone healing and preventing joint degeneration, it is essential to… Read more about this study

Who is it for?
Ages 0 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Fracture, Lengthening; Leg, Orthopedic Disorder
What is being tested?
Pediatric orthopaedic implant
Type of treatment
Medical device
How many people
4,000 participants
Where
1 siteCanada
Study dates
6 Jan 2022to Dec 2029
How long will I take part?
2 Years
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: Anyone who meets the eligibility criteria and is within the age limits listed in the above sections can participate in this study.

Who may be able to join

  • Patients indicated for the device-specific indication, per physician discretion and as indicated in the device IFU. Off-label use is strongly discouraged; however, any and all on- and off-label indications for use of the products in this program will be collected and stratified accordingly
  • Patients must be able to adhere to the required length of follow-up for the endpoints of each individual product
  • Informed consent/assent is required

Who cannot join

  • Patients with a demonstrated sensitivity to metals
  • Patients with an inability to follow a post-operative regimen

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Bryn Zomar, PhD contact

604-875-2359

bryn.zomar@cw.bc.ca

Harpreet Chhina, PhD contact

604-875-2000 ext. 6008

hchhina@cw.bc.ca

Canada1 site, 1 recruiting
  • BC Children's Hospital

    Vancouver, British Columbia, V6H 3N1

    Emily Schaeffer, PhD, 604-875-2359, emily.schaeffer@cw.bc.ca

    Anthony Cooper, FRCSC

    Recruiting

Other trials in Canada

About this study

Official title: Global Pediatric Orthopaedic Implant Safety & Efficacy Clinical Follow-up Program

Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity.

Given the vital role fixation devices play in maintaining alignment, promoting healthy bone healing and preventing joint degeneration, it is essential to understand the expected lifetime outcomes of these implants, and evaluate their safety and efficacy.

Prospective implant efficacy and safety registries are needed to support this endeavour, especially considering new regulatory requirements from the European Union Medical Devices Regulation (EU MDR) in relation to post-market clinical follow-up (PMCF).

Read the detailed description

STUDY PROCEDURES Screening Patients will be screened against basic inclusion/exclusion criteria to see if patients may be appropriate for study participation according to any standard of care assessments available, and where appropriate with the site's REB/IRB screening procedures and local regulatory requirements. If a patient is deemed eligible, data outlined throughout this protocol will be collected, de-identified and entered into a Research Electronic Database Capture (REDCap) system managed at BCCH.

Enrollment Patients will be assigned a sequential, unique study number (subject ID) and de-identified data will be entered in the study database. The center number is designated by the BCCH team for each individual investigational site. The patient number will be in sequential order by the patient screening date starting with 001. Once a patient has been assigned a subject ID, the number will not be reused.

Pre-Operative Procedures Once a patient is identified as eligible for an Implant Safety and Efficacy device report, it will be determined whether that patient is already enrolled in one of the existing condition-specific registries. Should participants be enrolled in a condition-specific registry, demographic data, medical history, preoperative clinical data, including any pre-existing infections at or near the operative site, and data on pre-operative radiographs for the relevant underlying diagnosis will have already been prospectively collected under registry procedures. If a patient has not been previously enrolled in a condition-specific registry, the patient will be offered enrollment in both the condition registry and for the purposes of the Implant Safety and Efficacy device report. Demographic data, medical history, preoperative clinical data and data on pre-operative radiographs for the relevant underlying diagnosis will then be collected retrospectively from the medical record.

Required Data Collection:

Operative details in the source documentation will be collected that provide specific information from the subject's surgery such as surgical approach, complications, and unique device identification (UDI) numbers for the implanted device.

The following data will be collected and entered into the registry:

  • Operative data, specific to the technique related to the relevant OrthoPediatrics system/device
  • Assessments of any device-related adverse events
  • Assessment for other adverse events
  • When possible, the UDI number for the device(s) implanted, or information on the device implanted

Follow-up Procedures

Data collected during routine standard of care follow-up visits will be collected as part of this study. The following data will be collected:

  • Radiographs obtained during study clinical evaluations to determine bony union, as well as healing or complications
  • Device-related adverse events
  • Unanticipated device-related serious adverse device effects
  • Information on implant removals not related to an adverse event; degree of bony union just prior to implant removal Unscheduled Visits [if or when needed]

The condition-specific registries are designed to capture every visit that occurs, whether scheduled or unscheduled. An unscheduled visit may occur when an adverse event occurs, or when a patient returns outside of the planned interval window. If an unscheduled visit occurs, the following assessments are to be done:

  • Assessment of any adverse events related to the device
  • Survivorship of the device
Being tested
Pediatric orthopaedic implant
Medical subject headings
Fractures, Bone, Musculoskeletal Diseases, Congenital Abnormalities, Hip Dislocation, Precursor Cell Lymphoblastic Leukemia-Lymphoma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pediatric orthopaedic implantDevice

    Patient receives a pediatric orthopaedic implant as a part of standard clinical care.

Study groups in NCT05361980
Study groupRoleWhat they receive
Longitudinal Observational GroupPediatric patients indicated for the device-specific indication, per physician discretion and as indicated in the device IFU.
Receives: Device: Pediatric orthopaedic implant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Device related adverse events

    Determine the frequency and severity of device-related adverse events at device-specific end points. All adverse events will be recorded and followed during the study. The frequency and severity of device related adverse events will be analyzed to ensure the device risk profile has not changed.

    Measured: 2 years post implant insertion

  2. Implant survival

    Determine the implant survival rate at post-operative end-point: (lack of revision)

    Measured: 2 years post implant insertion

  3. Implant efficacy

    Efficacy will be assessed by post-operative clinical and radiographic evaluations at each follow-up end-point to assess bone fixation and/or deformity correction.

    Measured: 2 years post implant insertion

Secondary outcomes (3)
  1. Numeric pain rating scale (NPRS)

    The numeric pain rating scale (NPRS) is a subjective, 11-point numerical scale in which respondents self-report their pain on a scale of 0 (no pain at all) to 10 (worst pain imaginable).

    Measured: 2 years post implant insertion

  2. LIMB-Q Kids

    LIMB-Q Kids is a new patient reported outcome measure (PROM) for children with lower limb deformities.

    Measured: 2 years post implant insertion

  3. PROMIS

    The Patient Reported Outcomes Measurement Information System (PROMIS) measures are self-reported and parent-reported. It includes over 300 measures of global, physical, mental, and social health for adults and children in the general population and those living with a chronic condition. Specifically, the PROMIS Global Health will be administered to all patients while the PROMIS Physical Function - Mobility short form will be administered to those with an implant used in a lower extremity and the PROMIS Physical Function - Upper Extremity short form will be administered to those with an implant used in an upper extremity.

    Measured: 2 years post implant insertion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2022
  2. Study start6 Jan 2022
  3. Primary completionDec 2028 (estimated)
  4. Study completionDec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
4,000 participants (estimated)
Target duration
2 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT05361980
Sponsor's protocol ID
H21-03076
Acronym
Global POISE
Status last verified
Nov 2025
First submitted
17 Dec 2021
Last updated
24 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Fracture and Lengthening; Leg, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bryn Zomar, PhD (604-875-2359, bryn.zomar@cw.bc.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Device related adverse events (time frame: 2 years post implant insertion). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in